By Kelly A. Briganti, Editorial Director, G2 Intelligence
The Centers for Medicare & Medicaid Services (CMS) will publish a proposed rule in the Oct. 1 Federal Register implementing the Protecting Access to Medicare Act of 2014 (PAMA) and requiring Applicable Laboratories to report private payer reimbursement data regarding laboratory testing.
Applicable Laboratories would be those receiving at least $50,000 under the…
Read more...
 Ready to make a positive impact on your laboratory's profitability? Diminishing reimbursements and an increasing demand for data are causing many laboratories to look for innovative ways to reduce costs, increase collections and gain better visibility to key performance indicators that drive profitability. TELCOR Revenue Cycle Management was developed specifically for laboratories to help manage the unique challenges encountered every day that can impact profitability. To discover more, visit telcor.com or email telcor@telcor.com.
By Ron Shinkman, Editor, Laboratory Industry Report
Florida-based molecular laboratory NeoGenomics has introduced a new test focused on providing more diagnostic information for women who have abnormal pap smears.
The test, known as the NeoSITE Cervical Assay, is an expansion of NeoGenomics' FISH testing menu. It will focus on abnormalities in five chromosomal locations. The test can be used for monitoring cancerous and precancerous lesions, as well as diagnosis and…
Read more...
By Kelly A. Briganti, Editorial Director, G2 Intelligence
What the Institute of Medicine (IOM) did for the discussion of medical errors in its To Err is Human report, it now seeks to do for diagnostic errors with the latest installment of its Quality Chasm Series titled Improving Diagnosis in Health Care. Released September 22, the report asserts that "[i]mproving the diagnostic process is not only possible, but also represents a moral, professional, and public health imperative." "Diagnostic errors are a significant contributor to patient harm that has received far too little attention until…
Read more...
 At Cleveland Clinic Laboratories, we strive to deliver high-quality, clinically impactful, and cost-effective laboratory diagnostics and consultative services that are crucial to outstanding patient care. With a team of nearly 100 pathologists and over 1,500 employees, our laboratories perform testing that improves diagnosis, prognosis and monitoring for our regional, national, and international patients.
For more information about Cleveland Clinic Laboratories, please visit our website clevelandcliniclabs.com or contact Dajan Ninic at 216-219-5670 or ninicd@ccf.org.
By Lori Solomon, Editor, Diagnostic Testing & Emerging Technologies
A new survey shows 73 percent of Americans are aware of genetic testing for hereditary cancers—a significant increase over just a few years ago that is largely attributed to the "Angelina Jolie Effect." However, the survey also found that many lack knowledge of their own family health history and there is a strong desire for guidance when considering genetic testing. As a result, genetic testing company Invitae (San Francisco), which sponsored the survey, is launching a new…
Read more...
By Kelly A. Briganti, Editorial Director, G2 Intelligence
Ready, set, go. ICD-10 implementation finally becomes a reality this Thursday on October 1, 2015. Centers for Medicare & Medicaid Services' ICD-10 Ombudsman Dr. Bill Rogers issued a press release last week heralding the event and praising ICD-10 as a resource to help better identify and treat patients' medical issues, coordinate care, and "support new payment methods that drive…
Read more...
|
